PRE News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

PR

Mkt Cap

$361.9M

Volume

319.26K

Next Earnings

November 9th

Loading chart

PR

PREPrenetics Global Limited Class A Ordinary Share

PRE

Pay with—

Available Balance0.00

PR

Mkt Cap

$395.4M

Volume

319.26K

Next Earnings

November 9th

Chart Bitcoin Treasury Financials Earnings News About Insider Filings

Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter ResultsPrenetics Global Limited (NASDAQ: PRE) announced that CEO Danny Yeung and CFO Brian Rosin purchased $1.0 million in company shares during August 2026, bringing cumulative leadership investment to $3.75 million since November 2025. The purchases follow strong Q2 2026 results with total revenue up 288% YoY to $46.5 million, IM8 revenue reaching $45.0 million (up 359% YoY), and the company achieving its first month of positive consolidated Adjusted Free Cash Flow in July. Prenetics raised FY 2026 revenue guidance to $220-230 million and introduced FY 2027 guidance of over $400 million.GlobeNewswire Inc. · Aug 26, 2026

Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)Prenetics Global Limited announced a $1 billion growth financing deal with General Catalyst's Customer Value Fund to accelerate IM8's marketing spend. The company raised its full-year 2026 revenue guidance to $210-220 million (from $190-210 million) and projects $300 million annualized run-rate by year-end 2026 and $400+ million in full-year 2027 revenue. IM8, co-founded by David Beckham, has become the fastest-growing premium supplement brand ever, delivering 200,000 servings daily across 43 countries with strong unit economics ($1.44 gross profit return per $1 acquisition spend).GlobeNewswire Inc. · Jul 14, 2026

Prenetics' IM8 Partners with Superpower to Personalize the Future of SupplementationPrenetics Global Limited's IM8 brand has partnered with Superpower to create an integrated health platform combining clinical-grade supplements with comprehensive blood biomarker testing. IM8 90-day subscribers can access Superpower's annual blood testing membership for $49 (75% discount), while Superpower members gain access to IM8's Daily Ultimate Essentials at preferred rates. The partnership aims to provide measurable proof of supplement efficacy through a closed-loop testing and supplementation system.GlobeNewswire Inc. · Mar 24, 2026

Personalized Nutrition Market Set to Reach $30.94 Billion by 2030 at 14.4% CAGR | Asia Pacific Emerging as a High-Growth HubThe global personalized nutrition market is projected to grow from $15.79 billion in 2025 to $30.94 billion by 2030 at a 14.4% CAGR. Digital tools and active measurement technologies are the fastest-growing segments, while Asia Pacific emerges as a high-growth regional hub driven by expanding middle class, rising lifestyle diseases, and rapid digital health adoption.GlobeNewswire Inc. · Mar 11, 2026

Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted LiquidityPrenetics Global Limited completed the sale of its 35% equity interest in Insighta to Tencent for $70 million in cash, bringing total adjusted liquidity to $171.1 million. The company operates with zero debt and plans to use the proceeds to accelerate IM8's global expansion. IM8, co-founded with David Beckham, has achieved over $100 million in annualized recurring revenue within 11 months and is sold in more than 30 countries.GlobeNewswire Inc. · Feb 17, 2026

Prenetics Global Limited Announces Proposed Public OfferingPrenetics Global Limited is launching a public offering of shares to fund global expansion of its IM8 health supplement brand and strategic Bitcoin accumulation, with plans to continue purchasing 1 Bitcoin daily.GlobeNewswire Inc. · Oct 25, 2025

Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 HealthDavid Beckham, a strategic investor in Prenetics, has launched a new health and wellness brand called IM8. IM8 offers two premium products, Daily Ultimate Essentials and Daily Ultimate Longevity, which are now available for purchase globally.GlobeNewswire Inc. · Nov 18, 2024

Prenetics Announces First Quarter 2024 Financial ResultsFirst Quarter Revenue Increased 30.2% and Gross Profit Increased 159.8% from Prior Year QuarterGlobeNewswire Inc. · Jun 18, 2024

Prenetics Announces Fourth Quarter and Full Year 2023 Financial ResultsHONG KONG, April 01, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics-driven health sciences company, today announced unaudited financial results for the fourth quarter and full year ended December 31, 2023, along with recent business updates.GlobeNewswire Inc. · Apr 1, 2024

Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station(From left: Dr. Ghada Alsaleh, Sonia Pawelczyk, Danny Yeung, Dr. James L. Green, Ahmed Alfandi, Dr. Tara Ruttley, Wasim Ahmed, Dr. Hilde Stenuit, Dr. Camille Alleyne at the MOU signing ceremony in Dubai, UAE Space Agency)GlobeNewswire Inc. · Feb 9, 2024

to start trading

PR

PREPrenetics Global Limited Class A Ordinary Share

PRE

Pay with—

Available Balance0.00

Your PositionYou don't own any PRE yet.

Related Tickers

Earnings